SI-BONE

Company Description

SI-BONE, Inc. is a medical device company focused on solving musculoskeletal disorders of sacropelvic anatomy; it specializes in minimally invasive surgical implant systems for sacroiliac joint dysfunction, pelvic fixation, and pelvic fractures. Its main businesses include iFuse, iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite implant systems. The company operates within the United States. In the last fiscal year, the company had a market cap of $727 million, profits of $132 million, revenue of $167 million, and 349 employees.

Analysis

ANALYSIS: With an Obermatt 360° View of 82 (better than 82% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock SI-BONE are very positive. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for SI-BONE. The consolidated Growth Rank has a good rank of 95, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. This means that growth is higher than for 95% of competitors in the same industry. The consolidated Safety Rank at 62 means that the company has a financing structure that is safer than 62% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a good rank of 78, which means that professional investors are more optimistic about the stock than for 78% of alternative investment opportunities. But the consolidated Value Rank is less desirable at 24, meaning that the share price of SI-BONE is on the higher side compared with indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 76% of alternative stocks in the same industry. ...read more

Country

USA

Industry Health Care Equipment

Size Small

Website si-bone.com

Index

NASDAQ

Add to Watchlist

See Similar Stocks

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.